Varex Imaging Corp
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction … Read more
Varex Imaging Corp (VREX) - Net Assets
Latest net assets as of December 2025: $490.80 Million USD
Based on the latest financial reports, Varex Imaging Corp (VREX) has net assets worth $490.80 Million USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.10 Billion) and total liabilities ($607.20 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $490.80 Million |
| % of Total Assets | 44.7% |
| Annual Growth Rate | 2.8% |
| 5-Year Change | -1.99% |
| 10-Year Change | -9.27% |
| Growth Volatility | 15.38 |
Varex Imaging Corp - Net Assets Trend (2014–2025)
This chart illustrates how Varex Imaging Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Varex Imaging Corp (2014–2025)
The table below shows the annual net assets of Varex Imaging Corp from 2014 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $486.60 Million | -11.40% |
| 2024-09-30 | $549.20 Million | -5.47% |
| 2023-09-30 | $581.00 Million | +6.27% |
| 2022-09-30 | $546.70 Million | +10.11% |
| 2021-09-30 | $496.50 Million | +6.59% |
| 2020-09-30 | $465.80 Million | +1.30% |
| 2019-09-30 | $459.80 Million | +4.64% |
| 2018-09-30 | $439.40 Million | +12.61% |
| 2017-09-30 | $390.20 Million | -27.24% |
| 2016-09-30 | $536.30 Million | +8.21% |
| 2015-09-30 | $495.60 Million | +37.93% |
| 2014-09-30 | $359.30 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Varex Imaging Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 590000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $400.00K | 0.08% |
| Other Comprehensive Income | $-5.20 Million | -1.10% |
| Other Components | $483.30 Million | 102.26% |
| Total Equity | $472.60 Million | 100.00% |
Varex Imaging Corp Competitors by Market Cap
The table below lists competitors of Varex Imaging Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Boozt AB
ST:BOOZT
|
$467.87 Million |
|
Sayona Mining Limited American Depository Shares
NASDAQ:ELVR
|
$467.91 Million |
|
Mingchen Health Co Ltd Class A
SHE:002919
|
$467.92 Million |
|
Doctorglasses Chain Co Ltd
SHE:300622
|
$467.95 Million |
|
Farmland Partners Inc
NYSE:FPI
|
$467.58 Million |
|
DroneShield Limited
PINK:DRSHF
|
$467.01 Million |
|
The ODP Corporation
MX:ODP
|
$466.85 Million |
|
Medios AG
PINK:MEDOF
|
$466.82 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Varex Imaging Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 535,100,000 to 472,600,000, a change of -62,500,000 (-11.7%).
- Net loss of 70,300,000 reduced equity.
- Other comprehensive income decreased equity by 2,300,000.
- Other factors increased equity by 10,100,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-70.30 Million | -14.88% |
| Other Comprehensive Income | $-2.30 Million | -0.49% |
| Other Changes | $10.10 Million | +2.14% |
| Total Change | $- | -11.68% |
Book Value vs Market Value Analysis
This analysis compares Varex Imaging Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.99x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.21x to 0.99x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-09-30 | $9.36 | $11.34 | x |
| 2015-09-30 | $12.62 | $11.34 | x |
| 2016-09-30 | $13.70 | $11.34 | x |
| 2017-09-30 | $9.97 | $11.34 | x |
| 2018-09-30 | $11.10 | $11.34 | x |
| 2019-09-30 | $11.55 | $11.34 | x |
| 2020-09-30 | $11.64 | $11.34 | x |
| 2021-09-30 | $11.99 | $11.34 | x |
| 2022-09-30 | $12.82 | $11.34 | x |
| 2023-09-30 | $11.29 | $11.34 | x |
| 2024-09-30 | $13.12 | $11.34 | x |
| 2025-09-30 | $11.42 | $11.34 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Varex Imaging Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -14.88%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -8.32%
- • Asset Turnover: 0.76x
- • Equity Multiplier: 2.34x
- Recent ROE (-14.88%) is below the historical average (5.41%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 30.64% | 16.07% | 1.58x | 1.21x | $74.17 Million |
| 2015 | 16.51% | 12.65% | 1.08x | 1.20x | $31.54 Million |
| 2016 | 13.02% | 11.05% | 1.00x | 1.18x | $15.90 Million |
| 2017 | 13.61% | 7.39% | 0.67x | 2.74x | $13.70 Million |
| 2018 | 6.45% | 3.56% | 0.78x | 2.32x | $-15.12 Million |
| 2019 | 3.48% | 1.99% | 0.75x | 2.33x | $-29.10 Million |
| 2020 | -12.82% | -7.84% | 0.65x | 2.52x | $-103.07 Million |
| 2021 | 3.60% | 2.13% | 0.71x | 2.37x | $-30.93 Million |
| 2022 | 5.68% | 3.53% | 0.73x | 2.22x | $-23.04 Million |
| 2023 | 8.49% | 5.40% | 0.71x | 2.20x | $-8.57 Million |
| 2024 | -8.91% | -5.88% | 0.67x | 2.27x | $-101.21 Million |
| 2025 | -14.88% | -8.32% | 0.76x | 2.34x | $-117.56 Million |
Industry Comparison
This section compares Varex Imaging Corp's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Varex Imaging Corp (VREX) | $490.80 Million | 30.64% | 1.24x | $467.60 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |